Advanced Ultrasound in Diagnosis and Therapy ›› 2026, Vol. 10 ›› Issue (4): 245-258.doi: 10.26599/AUDT.2026.250115
• ORIGINAL RESEARCH • Previous Articles Next Articles
Sui Yajuana,1, Meng Wenyia,1, Li Renjiea, Li Lujinga,*(
), Xu Zuofenga,*(
)
Received:2025-12-08
Revised:2026-04-13
Accepted:2026-07-04
Online:2026-12-30
Published:2026-11-02
Contact:
Li Lujing, Xu Zuofeng,
E-mail:lilj23@mail.sysu.edu.cn;xuzf@mail.sysu.edu.cn
About author:First author contact:1Yajuan Sui and Wenyi Meng contributed equally to this study.
Sui Yajuan, Meng Wenyi, Li Renjie, Li Lujing, Xu Zuofeng. Knowledge Mapping of Ultrasound-guided Thermal Ablation Combined with Immunotherapy for Hepatocellular Carcinoma: A Systematic Bibliometric Analysis. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 245-258.
Table 1
Top 10 most productive institutions."
| Institution | Articles |
| Sun Yat-sen University | 46 |
| Zhejiang University | 31 |
| Huazhong University of Science and Technology | 28 |
| Fudan University | 24 |
| National Cancer Institute | 21 |
| The University of Texas MD Anderson Cancer Center | 20 |
| Jinan University | 19 |
| Soochow University | 17 |
| Memorial Sloan-Kettering Cancer Center | 16 |
| Shanghai Jiaotong University | 15 |
Table 2
Top 10 most productive authors and their co-citation counts."
| Rank | Author | Articles | Co-cited author | Citations |
| 1 | Ping Liang | 13 | Josep M. Llovet | 3383 |
| 2 | Tim F Greten | 11 | Riccardo Lencioni | 3236 |
| 3 | Chuansheng Zheng | 11 | Augusto Villanueva | 2897 |
| 4 | S. Nahum Goldberg | 10 | Amit G. Singal | 2836 |
| 5 | Shuichi Kaneko | 10 | Kazuhiko Koike | 2774 |
| 6 | Eishiro Mizukoshi | 10 | Eli Pikarsky | 2755 |
| 7 | Xin Li | 10 | Richard S. Finn | 2750 |
| 8 | Bradford J. Wood | 9 | Robin Kate Kelley | 2750 |
| 9 | Xinhua Chen | 8 | Sasan Noayaie | 2750 |
| 10 | Kuniaki Arai Jun Wang Tatsuya Yamashita Jibing Chen Zhen Xu Jie Yu Xuefeng Kan Feng Wu | 7 | Jessica Zucman-Rossi | 2750 |
Table 3
Top 10 most cited articles."
| Frequence | Author | Year | Journal | DOI |
| 170 | Richard S Finn | 2020 | New England Journal of Medicine | 10.1056/NEJMoa1915745 |
| 118 | Anthony B El-Khoueiry | 2017 | The Lancet Oncology | 10.1016/S0140-6736(17)31046-2 |
| 92 | Andrew X Zhu | 2018 | The Lancet | 10.1016/S1470-2045(18)30351-6 |
| 87 | Masatoshi Kudo | 2018 | The Lancet | 10.1016/S0140-6736(18)30207-1 |
| 86 | Richard S Finn | 2020 | Journal of Clinical Oncology | 10.1200/JCO.19.01307 |
| 86 | Austin G Duffy | 2017 | Journal of Hepatology | 10.1016/j.jhep.2016.10.029 |
| 83 | Maria Reig | 2022 | Journal of Hepatology | 10.1016/j.jhep.2021.11.018 |
| 74 | European Association for the Study of the Liver | 2018 | Journal of Hepatology | 10.1016/j.jhep.2018.03.019 |
| 73 | Hyuna Sung | 2021 | CA: A Cancer Journal for Clinicians | 10.3322/caac.21660 |
| 68 | Ghassan K Abou-Alfa | 2018 | New England Journal of Medicine | 10.1056/NEJMoa1717002 |
| [1] |
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.
doi: 10.3322/caac.21834 |
| [2] |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.
doi: 10.3322/caac.21660 |
| [3] |
Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PKH, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology 2023; 164: 766-782.
doi: 10.1053/j.gastro.2023.01.033 |
| [4] | Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74: 12-49. |
| [5] |
Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 2023; 20: 37-49.
doi: 10.1038/s41575-022-00688-6 |
| [6] |
GBD 2019 Diseases, Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204-1222.
doi: 10.1016/S0140-6736(20)30925-9 |
| [7] |
Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol 2023; 78: 471-478.
doi: 10.1016/j.jhep.2022.11.010 |
| [8] |
Zhu Q, Ma Y, Liang J, Wei Z, Li M, Zhang Y, et al. AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduction Targeted Ther 2021; 6: 299.
doi: 10.1038/s41392-021-00713-1 |
| [9] |
Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, et al. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol 2023; 8: 829-836.
doi: 10.1016/S2468-1253(23)00157-7 |
| [10] |
Marti-Aguado D, Clemente-Sanchez A, Bataller R. Cigarette smoking and liver diseases. J Hepatol 2022; 77: 191-205.
doi: 10.1016/j.jhep.2022.01.016 |
| [11] |
Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet 2022; 400: 1345-1362.
doi: 10.1016/S0140-6736(22)01200-4 |
| [12] | Lee MW, Han S, Gu K, Rhim H. Local ablation therapy for hepatocellular carcinoma: Clinical significance of tumor size, location, and biology. Invest Radiol 2024; 60: 53-59. |
| [13] |
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 6.
doi: 10.1038/s41572-020-00240-3 |
| [14] |
Baust JG, Snyder KK, Santucci KL, Robilotto AT, Van Buskirk RG, Baust JM. Cryoablation: physical and molecular basis with putative immunological consequences. Int J Hyperthermia 2019; 36: 10-16.
doi: 10.1080/02656736.2019.1647355 |
| [15] |
Shewarega A, Santana JG, Nam D, Berz A, Tefera J, Kahl V, et al. Effect of incomplete cryoablation and matrix metalloproteinase inhibition on intratumoral CD8+ T-cell infiltration in murine hepatocellular carcinoma. Radiology 2024; 310: e232365.
doi: 10.1148/radiol.232365 |
| [16] |
Partridge BR, O'Brien TJ, Lorenzo MF, Coutermarsh-Ott SL, Barry SL, Stadler K, et al. High-frequency irreversible electroporation for treatment of primary liver cancer: A proof-of-principle study in canine hepatocellular carcinoma. J Vasc Interv Radiol 2020; 31: 482-91.e4.
doi: 10.1016/j.jvir.2019.10.015 |
| [17] |
Bulvik BE, Rozenblum N, Gourevich S, Ahmed M, Andriyanov AV, Galun E, et al. Irreversible electroporation versus radiofrequency ablation: A comparison of local and systemic effects in a small-animal model. Radiology 2016; 280: 413-424.
doi: 10.1148/radiol.2015151166 |
| [18] |
European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236.
doi: 10.1016/j.jhep.2018.03.019 |
| [19] | Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2017; 67: 358-380. |
| [20] |
Xie D, Shi J, Zhou J, Fan J, Gao Q. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective. Clin Mol Hepatol 2023; 29: 206-216.
doi: 10.3350/cmh.2022.0402 |
| [21] |
Barrow B, Martin Ii RCG. Microwave ablation for hepatic malignancies: a systematic review of the technology and differences in devices. Surg Endosc 2023; 37: 817-834.
doi: 10.1007/s00464-022-09567-2 |
| [22] |
Nieuwenhuizen S, Dijkstra M, Puijk RS, Geboers B, Ruarus AH, Schouten EA, et al. Microwave ablation, radiofrequency ablation, irreversible electroporation, and stereotactic ablative body radiotherapy for intermediate size (3-5 cm) unresectable colorectal liver metastases: a systematic review and meta-analysis. Curr Oncol Rep 2022; 24: 793-808.
doi: 10.1007/s11912-022-01248-6 |
| [23] |
Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, et al. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 2017; 66: 545-551.
doi: 10.1016/j.jhep.2016.10.029 |
| [24] |
Bitar R, Salem R, Finn R, Greten TF, Goldberg SN, Chapiro J. Interventional oncology meets immuno-oncology: Combination therapies for hepatocellular carcinoma. Radiology 2024; 313: e232875.
doi: 10.1148/radiol.232875 |
| [25] |
Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021; 18: 293-313.
doi: 10.1038/s41575-020-00395-0 |
| [26] |
Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, et al. Radiofrequency ablation and microwave ablation in liver tumors: An update. Oncologist 2019; 24: e990-e1005.
doi: 10.1634/theoncologist.2018-0337 |
| [27] |
Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr 2021; 10: 193-209.
doi: 10.21037/hbsn.2020.03.11 |
| [28] |
Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res 2021; 133: 285-296.
doi: 10.1016/j.jbusres.2021.04.070 |
| [29] |
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 2020; 382: 1894-1905.
doi: 10.1056/NEJMoa1915745 |
| [30] | Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria-a 10-year update. Radiology 2014; 273: 241-260. |
| [31] |
Cheng PL, Wu PH, Kao WY, Lai YT, Hsu JC, Chiou JF, et al. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis. Exp Hematol Oncol 2023; 12: 37.
doi: 10.1186/s40164-023-00400-7 |
| [32] |
Tian Y, Qi X, Jiang X, Shang L, Xu K, Shao H. Cryoablation and immune synergistic effect for lung cancer: A review. Front Immunol 2022; 13: 950921.
doi: 10.3389/fimmu.2022.950921 |
| [33] |
Chen S, Zeng X, Su T, Xiao H, Lin M, Peng Z, et al. Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective. Front Immunol 2022; 13: 1033000.
doi: 10.3389/fimmu.2022.1033000 |
| [34] |
Feng X, Xu R, Du X, Dou K, Qin X, Xu J, et al. Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0–B1 hepatocellular carcinoma: A multicenter retrospective cohort study. Am J Gastroenterol 2014; 109: 1891-1899.
doi: 10.1038/ajg.2014.343 |
| [35] |
Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J Hyperthermia 2020; 37: 384-391.
doi: 10.1080/02656736.2020.1752400 |
| [36] |
Tang Q, Wang Y, Yan B, Zhang J, Wang T, Fang Y, et al. Intracellular magnetic hyperthermia sensitizes sorafenib to orthotopic hepatocellular carcinoma via amplified ferroptosis. ACS Nano 2024; 18: 29804-29819.
doi: 10.1021/acsnano.4c09500 |
| [37] |
Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 2018; 391: 1163-1173.
doi: 10.1016/S0140-6736(18)30207-1 |
| [38] |
Wen J, Zhang X, Wong CC, Zhang Y, Pan Y, Zhou Y, et al. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma. Gut 2024; 73: 2023-2036.
doi: 10.1136/gutjnl-2023-331117 |
| [39] |
Shi L, Chen L, Wu C, Zhu Y, Xu B, Zheng X, et al. PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor. Clin Cancer Res 2016; 22: 1173-1184.
doi: 10.1158/1078-0432.CCR-15-1352 |
| [40] |
Zhou C, Li Y, Li J, Song B, Li H, Liang B, et al. A phase 1/2 multicenter randomized trial of local ablation plus toripalimab versus toripalimab alone for previously treated unresectable hepatocellular carcinoma. Clin Cancer Res 2023; 29: 2816-2825.
doi: 10.1158/1078-0432.CCR-23-0410 |
| [1] | Khatami Seyedeh Mohaddeseh, Rahmani Arash, Liu Ji-Bin, Eisenbrey John. Ultrasound-Stimulated Microbubbles in Cancer Therapy: A Review of Clinical and Translational Evidence [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 264-276. |
| [2] | Cao Jiaying, Li Wenying, Qiu Yijie, Wei Li, Wang Ying, Huang Yunlin, Dong Yi, Dietrich Christoph F. Decoding Hepatocellular Carcinoma Heterogeneity with Multimodal Ultrasound and Acoustic Radiomics [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 334-345. |
| [3] | Zhan Cuiping, Han Xiao, Huang Qingbo, Shi Xian-Quan. Ultrasound-guided Transperineal Prostate Thermal Ablation: Advances in Benign Prostatic Hyperplasia [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(3): 127-136. |
| [4] | Liu Taixia, Wang Hanxiang, Wang Dan, Zhang Yuke, Guo Yunyun, Liu Shuo, Zhang Minfeng, Nie Hongming, Shen Rui. The Role of Sonazoid-contrast-enhanced Ultrasound In Precision Diagnosis and Guidance for Radiofrequency Ablation Therapy of Hepatocellular Carcinoma: a Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(1): 20-28. |
| [5] | Xu Junmei, Tahmasebi Aylin, Mohammed Amr, Pour Bahareh Kian, Liu Ji-Bin, Eisenbrey John R.. Contrast-enhanced Ultrasound LI-RADS for Nonradiation Treatment Response Assessment in Liver Tumor: A Pictorial Review Based on LR-TR v2024 [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(4): 357-374. |
| [6] | Yu Xiao jie, Song Zheng lai, Chang Xue yong, Yu Jie, Liang Ping. Artificial Intelligence in Ultrasound Diagnosis of Liver Nodules: A Comprehensive Review of B-Mode and Contrast-enhanced Applications [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(4): 326-346. |
| [7] | Guan Xin, Hu Xinyuan, Han Hong, Zhang Dezhi, Xu Huixiong. The Evolving Application of Ultrasound in the Precision Management of Small Hepatocellular Carcinoma [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(4): 375-387. |
| [8] | Liu Tong, Meng Kexin, Zhu Ying, Fan Fengjing, Wang Bei. Clinical Treatment Status of Papillary Thyroid Microcarcinoma [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(1): 41-46. |
| [9] | Yue Tian, MB, Yanan Zhao, MD, Yiran Huang, MB. The Diagnostic Value of Real-time Shear Wave Ultrasound Elastography in the Differentiation of Hepatic Hemangioma and Hepatocellular Carcinoma [J]. Advanced Ultrasound in Diagnosis and Therapy, 2024, 8(3): 124-129. |
| [10] | Osama Mahmoud, BS, Ajay Makkena, BS, Corinne E. Wessner, MS, MBA, RDMS, Ji-Bin Liu, MD, John R. Eisenbrey, PhD, Andrej Lyshchik, MD, PhD. Contrast-Enhanced Ultrasound LI-RADS: A Pictorial Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(4): 321-332. |
| [11] | Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD. Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(3): 254-257. |
| [12] | Mengna He, MD, PHD, Lu Zhu, MD, Tianan Jiang, MD, PHD. Findings of Fat Containing Hepatocellular Carcinoma on Contrast-enhanced Ultrasound with Sonazoid: A Case Report [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(2): 98-101. |
| [13] | Yan Zhou, Jianmin Ding, Fengmei Wang, Zhengyi Qin, Yandong Wang, Hongyu Zhou, Xiang Jing. The Effects of Liver Function Damage after Thermal Ablation on the Prognosis of HCC Patients and Its Prediction [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(2): 80-86. |
| [14] | Mengna He, MD, PhD, Lei Xu, MD, Tian’an Jiang, MD, PhD. Time-intensity Curve Analysis of Hepatocellular Carcinoma using Two Contrast-enhanced Ultrasound Methods: Contrast Pulse Sequencing and Contrast Harmonic Imaging [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(3): 217-222. |
| [15] | Li Ma, MD, Wenzhao Liang, MD, Yupeng Zhu, MD, Yingqiao Zhu, MD, Dezhi Zhang, MD. Differences in CEUS and CE-MRI Appearance of HCC: A Case Report [J]. Advanced Ultrasound in Diagnosis and Therapy, 2019, 3(4): 197-199. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
Share: WeChat
Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy
|
Advanced Ultrasound in Diagnosis and Therapy (AUDT) a>
is licensed under a Creative Commons Attribution 4.0 International License a>.
